Modulation of DNA adduct levels in human mononuclear white blood cells and granulocytes by CYP1A1, CYP2D6 and GSTM1 genetic polymorphisms

Mutation Research - Genetic Toxicology and Environmental Mutagenesis

Volumn 415, Issue 1-2, 1998, Pages 97-108

  Butkiewicz, Dorota ^a   Grzybowska, Ewa ^a   Hemminki, Kari ^b   Øvrebø, Steinar ^c   Haugen, Aage ^c   Motykiewicz, Grazyna ^a   Chora̧zy, Mieczysław ^a  

^a INSTITUTE OF ONCOLOGY   (Poland)

^b KAROLINSKA INSTITUTE   (Sweden)

^c NATIONAL INSTITUTE OF OCCUPATIONAL HEALTH   (Norway)

Author keywords

DNA adduct; Genetic susceptibility; Human WBC; Polymorphism

Indexed keywords

1 HYDROXYPYRENE; CYTOCHROME P450 ISOENZYME; GLUTATHIONE TRANSFERASE; POLYCYCLIC AROMATIC HYDROCARBON;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DNA ADDUCT; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; HUMAN CELL; LEUKOCYTE; MALE; MONOCYTE; MONONUCLEAR CELL; NORMAL HUMAN; PRIORITY JOURNAL; PROMYELOCYTE; SEASON; SUMMER; WINTER;

ADULT; AGED; CYTOCHROME P-450 CYP1A1; CYTOCHROME P-450 CYP2D6; DNA ADDUCTS; GLUTATHIONE TRANSFERASE; GRANULOCYTES; HUMANS; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC;

EID: 0031846133     PISSN: 13835718     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1383-5718(98)00064-3     Document Type: Article

References (44)

1. F. Oesch, H. Schmassmann, E. Ohnhaus, U. Althaus, J. Lorenz, Monooxygenase, epoxide hydrolase, and glutathione S-transferase activities in human lung. Variation between groups of bronchogenic carcinoma and non-cancer patients and interindividual differences, Carcinogenesis 1 (1980) 827-835.
2. H. Raunio, K. Husgafvel-Pursiainen, S. Anttila, E. Hietanen, A. Hirvonen, O. Pelkonen, Diagnosis of polymorphisms in carcinogen-activating and inactivating enzymes and cancer susceptibility - a review, Gene 159 (1995) 113-121.
3. S. Hayashi, J. Watanabe, K. Nakachi, K. Kawajiri, Genetic linkage of lung cancer-associated MspI polymorphisms with amino acid replacement in the heme binding region of the human cytochrome P450IA1 gene, J. Biochem. 110 (1991) 407-411.
4. S. Hayashi, J. Watanabe, K. Kawajiri, High susceptibility to lung cancer analyzed in terms of combined genotypes of P450IA1 and mu-class glutathione S transferase genes, Jpn. J. Cancer Res. 83 (1992) 866-870.
5. K. Nakachi, K. Imai, S. Hayashi, K. Kawajiri, Polymorphisms of the CYP1A1 and glutathione S-transferase genes associated with susceptibility to lung cancer in relation to cigarette dose in Japanese population, Cancer Res. 53 (1993) 2994-2999.
6. A. Hirvonen, K. Husgafvel-Pursiainen, A. Karjalainen, S. Anttila, H. Vainio, Point-mutational MspI and Ile-Val polymorphisms closely linked in the CYP1A1 gene: lack of association with susceptibility to lung cancer in a Finnish study population, Cancer Epidemiol. Biomarkers Prev. 1 (1992) 485-489.
7. N. Drakoulis, I. Cascorbi, J. Brockmoller, C.R. Gross, I. Roots, Polymorphisms in the human CYP1A1 gene as susceptibility factors for lung cancer: exon 7 mutation (4889A to G), and a T to C mutation in the 3′-flanking region, Clin. Invest. 72 (1994) 240-248.
8. A.-K. Alexandrie, M. Ingelman-Sundberg, J. Seidegard, G. Tornling, A. Rannung, Genetic susceptibility to lung cancer with special emphasis on CYP1A1 and GSTM1: a study on host factors in relation to age at onset, gender and histological cancer types, Carcinogenesis 15 (1994) 1785-1790.
9. M.R. Law, M.R. Hetzel, J.R. Idle, Debrisoquine metabolism and genetic predisposition to lung cancer, Br. J. Cancer. 59 (1989) 686-687.
10. N. Caporaso, R.B. Hayes, M. Dosemeci, R. Hoover, R. Ayesh, M. Hetzel, J. Idle, Lung cancer risk, occupational exposure and the debrisoquine metabolic phenotype, Cancer Res. 49 (1989) 3675-3679.
11. N. Caporaso, M.R. DeBaun, N. Rothman, Lung cancer and CYP2D6 (the debrisoquine polymorphism): sources of heterogeneity in the proposed association, Pharmacogenesis 5 (1995) S129-S134.
12. C.R. Wolf, C.A. Dale Smith, A.C. Gough, J.E. Moss, K.A. Vallis, G. Howard, F.J. Carey, K. Mills, W. McNee, J. Carmichael, N.K. Spurr, Relationship between the debrisoquine hydroxylase polymorphism and cancer susceptibility, Carcinogenesis 13 (1992) 1035-1038.
13. T. Tefre, A.K. Daly, M. Armstrong, J.B.S. Leathart, J.R. Idle, A. Brogger, A.-L. Borresen, Genotyping of the CYP2D6 gene in Norwegian lung cancer patients and controls, Pharmacogenetics 4 (1994) 47-57.
14. I. Stucker, J. Cosme, Ph. Laurent, S. Cenee, Ph. Beaune, J. Bignon, A. Depierre, B. Milleron, D. Hemon, CYP2D6 genotype and lung cancer risk according to histologic type and tobacco exposure, Carcinogenesis 16 (1995) 2759-2764.
15. C.L. Crespi, B.W. Penman, H.V. Gelboin, F.J. Gonzales, A tobacco smoke-derived nitrosoamine, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, is activated by multiple human cytochrome P450s including the polymorphic human cytochrome P4502D6, Carcinogenesis 12 (1991) 1197-1201.
16. B. Ketterer, J.M. Harris, G. Talaska, D.J. Meyer, S.E. Pemble, J.B. Taylor, N.P. Lang, F.F. Kadlubar, The human glutathione S-transferase supergene family, its polymorphism, and its effects on susceptibility to lung cancer, Environ. Health Persp. 98 (1992) 87-94.
17. C.C. Harris, Interindividual variation among humans in carcinogen metabolism, DNA adduct formation and DNA repair, Carcinogenesis 10 (1989) 1563-1566.
18. A. Hirvonen, Genetic factors in individual responses to environmental exposures, JOEM 37 (1995) 37-43.
19. E. Grzybowska, K. Hemminki, J. Szeliga, M. Chora̧ży, Seasonal variation of aromatic DNA adducts in human mononuclear white blood cells and granulocytes, Carcinogenesis 14 (1993) 2523-2526.
20. 32P-postlabeling test for structurally diverse DNA adducts, Carcinogenesis 7 (1986) 1543-1551.
21. K.E. Comstock, B.J.S. Sanderson, G. Claflin, W.D. Henner, GST1 gene deletion determined by polymerase chain reaction, Nucleic Acids Res. 18 (1990) 3670.
22. P.G. Shields, E.D. Bowman, A.M. Harrington, V.T. Doan, A. Weston, Polycyclic aromatic hydrocarbon-DNA adducts in human lung and cancer susceptibility genes, Cancer Res. 53 (1993) 3486-3492.
23. M. Heim, U.A. Meyer, Genotyping of poor metabolisers of debrisoquine by allele-specific PCR amplification, Lancet 336 (1990) 529-532.
24. S. Kato, E.D. Bowman, A.M. Harrington, B. Blomeke, P.G. Shields, Human lung carcinogen-DNA adduct levels mediated by genetic polymorphisms in vivo, J. Natl. Cancer Inst. 87 (1995) 902-907.
25. S. Øvrebø, P.E. Fjeldstad, E. Grzybowska, E.H. Kure, M. Chora̧ży, A. Haugen, Biological monitoring of polycyclic aromatic hydrocarbon exposure in a highly polluted area of Poland, Environ. Health Perspect. 103 (1995) 838-843.
26. A. Hirvonen, K. Husgafvel-Pursiainen, S. Anttila, H. Vainio, The GSTM1 null genotype as a potential risk modifier for squamous cell carcinoma of the lung, Carcinogenesis 14 (1993) 1479-1481.
27. 32P-HPLC, Carcinogenesis 17 (1996) 61-66.
28. K. Hemminki, E. Grzybowska, M. Chora̧ży, K. Twardowska-Saucha, J.W. Sroczyński, K.L. Putman, K. Randerath, D.H. Phillips, A. Hewer, R.M. Santella, T.L. Young, F.P. Perera, DNA adducts in humans environmentally exposed to aromatic compounds in an industrial area of Poland, Carcinogenesis 11 (1990) 1229-1231.
29. K. Hemminki, E. Grzybowska, M. Chora̧ży, K. Twardowska-Saucha, J.W. Sroczyński, K.L. Putman, K. Randerath, D.H. Phillips, A. Hewer, Aromatic DNA adducts in white blood cells of coke workers, Int. Arch. Occup. Environ. Health 62 (1990) 467-470.
30. E. Grzybowska, K. Hemminki, M. Chora̧ży, Seasonal variations in levels of DNA adducts and X-spots in human populations living in different parts of Poland, Environ. Health Perspect. 99 (1993) 77-81.
31. M. Chora̧ży, J. Szeliga, M. Stróżyk, B. Cimander, Ambient air pollutants in Upper Silesia: partial chemical composition and biological activity, Environ. Health Perspect. 102 (1994) 61-66, Suppl. 4.
32. G. Motykiewicz, B. Cimander, J. Szeliga, A. Tkocz, M. Chora̧ży, Mutagenic activity of complex air pollutants in Silesia, in: H. Vainio, M. Sorsa, A.J. McMichael (Eds.), Complex Mixtures and Cancer Risk IACR Scientific Publication no. 104, International Agency for Research on Cancer, Lyon, France, 1990, pp. 261-268.
33. G. Motykiewicz, M. Mańka, B. Cimander, M. Chora̧ży, Mutagenic activity in airborne particulate pollutants at industrial district of Silesia, Bull. Pol. Acad. Sci. 33 (1985) 1-6.
34. G. Motykiewicz, J. Szeliga, B. Cimander, M. Chora̧ży, Seasonal variations in mutagenic activity of air pollutants at an industrial district of Silesia, Mutat. Res. 223 (1989) 243-251.
35. D. Ryberg, A. Hewer, D.H. Phillips, A. Haugen, Different susceptibility to smoking-induced DNA damage among male and female lung cancer patients, Cancer Res. 54 (1994) 5801-5803.
36. M. Ichiba, L. Hagmar, A. Rannug, B. Hogstedt, A.-K. Alexandrie, U. Carstensen, K. Hemminki, Aromatic DNA adducts, micronuclei and genetic polymorphism for CYP1A1 and GST1 in chimney sweeps, Carcinogenesis 15 (1994) 1347-1352.
37. P.S. Nielsen, N. de Patter, H. Okkels, H. Autrup, Environmental air pollution and DNA adducts in Copenhagen bus drivers - effect of GSTM1 and NAT2 genotypes on adduct levels, Carcinogenesis 17 (1996) 1021-1027.
38. P.S. Nielsen, H. Okkels, T. Sigsgaard, S. Kyrtopoulos, H. Autrup, Exposure to urban and rural air pollution: DNA and protein adducts and effect of glutathione S-transferase genotype on adduct levels, Int. Arch. Occup. Environ. Health 68 (1996) 170-176.
39. N. Rothman, P.G. Shields, M.C. Poirier, A.M. Harrington, D.P. Ford, P.T. Strickland, The impact of glutathione S-transferase M1 and cytochrome P450 1A1 genotypes on white-blood-cell polycyclic aromatic hydrocarbon-DNA adduct levels in humans, Mol. Carcinog. 14 (1995) 63068.
40. S. Hou, B. Lambert, K. Hemminki, Relationship between hprt mutant frequency, aromatic DNA adducts and genotypes for GSTM1 and NAT2 in bus maintenance workers, Carcinogenesis 16 (1995) 1913-1917.
41. F. Crofts, E. Taioli, J. Trachman, G.N. Cosma, D. Currie, P. Toniolo, S.J. Garte, Functional significance of different human CYP1A1 genotypes, Carcinogenesis 15 (1994) 2961-2963.
42. 32P-postlabelling assay, Carcinogenesis 12 (1991) 503-508.
43. R. Ayesh, J.R. Idle, J.C. Ritchie, M.J. Crothers, M.R. Hetzel, Metabolic oxidation phenotypes as markers for susceptibility to lung cancer, Nature 312 (1984) 169-170.
44. C. Bouchardy, S. Benhamou, P. Dayer, The affect of tobacco on lung cancer risk depends on CYP2D6 activity, Cancer Res. 56 (1996) 251-253.